Valuation Bio-Rad Laboratories, Inc. NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:10:00 2026-08-20 pm EDT
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
+8.33% | +17.50% |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 10,309 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | 25.53% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 9,560 | 9,344 | 9,202 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | 21.41% | -2.26% | -1.51% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 46.9x | 45.9x | 46.2x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | - | - | - |
| PEG | - | - | - | -0x | -0x | -0.7x | 21.24x | -65.53x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 4.01x | 3.91x | 3.84x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 3.72x | 3.55x | 3.43x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 23.3x | 21.5x | 20.6x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 33.3x | 29.4x | 28x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 31.1x | 29.6x | 27.8x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 3.21% | 3.38% | 3.6% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.33 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,573 | 2,633 | 2,682 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 410.3 | 435 | 446.5 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 287.5 | 318.4 | 328.8 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 225 | 230 | 228 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 390.34 | 390.34 | 390.34 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,738 | - | - |
| Announcement Date | 2/10/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 33.47x | 4.49x | 17.25x | 2.2% | 201B | ||
| 20.92x | 3.61x | 12.74x | 3.2% | 117B | ||
| 17.73x | 0.21x | 12.94x | 0.74% | 62.6B | ||
| 30.33x | 7.54x | 19.27x | 1.32% | 52.49B | ||
| 36.76x | 3.52x | 12.05x | 2.06% | 51.69B | ||
| 36.5x | 6.42x | 20.17x | -.--% | 33.65B | ||
| 45.55x | 1.29x | 11.82x | 0.17% | 31.27B | ||
| 41.2x | 7.22x | 25.91x | 0.26% | 24.52B | ||
| 20.05x | 3.09x | 11.28x | 1.43% | 24.05B | ||
| Average | 31.39x | 4.15x | 15.94x | 1.26% | 66.43B | |
| Weighted average by Cap. | 29.96x | 4.05x | 15.64x | 1.81% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















